Russia launches another round of airstrikes in Syria. In Afghanistan, fighting with the Taliban continues in Kunduz. And a Palestinian flag flies at the U.N. for the first time. A panel of journalists joins guest host Melissa Block for analysis of the week's top international news stories.
Guest Host: Steve Roberts
A panel talks about the nations that have joined the U.S. war against terrorism, what kind of commitments they’ve made, and what further support will be needed if the war is to be successful.
- Phyllis Bennis Institute for Policy Studies and author of "Challenging Empire: How People, Governments, and the UN Defy US Power"
- Robin Wright journalist, author and foreign policy analyst at the United States Institute of Peace. Her most recent book is "Dreams and Shadows: The Future of the Middle East."
- George Perkovich Vice president for studies-global security and economic development-and director of the non-proliferation program at the Carnegie Endowment for International Peace. Pakistan?
- Amb. Karl Inderfurth former assistant secretary of state for south Asian affairs; professor and graduate program director at George Washington University's Elliott School of International Affairs
Most Recent Shows
Nine people and a gunman are dead after a shooting at an Oregon community college. Bernie Sanders narrows the fundraising gap with Hillary Clinton in the last quarter. And Congress avoids a government shutdown – for now. A panel of journalists joins guest host Melissa Block of NPR News for analysis of the week's top national news stories.
Russian President Putin is widely popular in Russia, despite his ruthless reputation abroad. A former Moscow bureau chief for The New York Times explains how Putin rose from obscurity to become one of the world’s most powerful and enigmatic leaders.
The owner of a drug company has come under fire for dramatically raising the price of medicine that fights deadly infections. And the prices of some heart medications have also spiked. We look at the renewed controversy over high drug prices in the U.S.